Why Is This Fast-Growing Biotech So Undervalued?
Antares Pharma (NASDAQ: ATRS) is one of the fastest-growing biotech stocks in the sector, with multiple collaboration agreements with large-cap pharmaceutical companies to supply it with pressure-assisted injector devices.
The wheel of fortune, however, has not been kind to Antares, as its shares are now down 40% year to date despite the company's record levels of revenue growth. Just what exactly could be keeping this stock down?
Image Source: Getty Images.
Source Fool.com
